Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0039 | 0.0316 | 0.1449 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0138 | 0.2182 | 0.2182 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0039 | 0.0316 | 0.1449 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0138 | 0.2182 | 0.2182 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0039 | 0.0316 | 0.0316 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0039 | 0.0316 | 0.0316 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0039 | 0.0316 | 0.1449 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0039 | 0.0316 | 0.1449 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0138 | 0.2182 | 0.2182 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0039 | 0.0316 | 0.1449 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0138 | 0.2182 | 0.2182 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0201 | 0.3371 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0039 | 0.0316 | 0.1449 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0039 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0047 | 0.0214 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.0553 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.0047 | 0.1478 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0039 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0138 | 0.2182 | 0.6109 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0039 | 0.0316 | 0.1449 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0193 | 0.3232 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0138 | 0.2182 | 0.6753 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0039 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0138 | 0.2182 | 0.2182 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0039 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0024 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0039 | 0.0316 | 0.1449 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0039 | 0.0316 | 0.0978 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0039 | 0.0316 | 0.0978 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0039 | 0.0316 | 0.1449 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Brugia malayi | P38 map kinase family protein 2 | 0.0138 | 0.2182 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0047 | 0.1478 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0138 | 0.2182 | 1 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0138 | 0.2182 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0039 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0024 | 0.0047 | 0.0214 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0138 | 0.2182 | 0.2182 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0138 | 0.2182 | 0.6753 |
Giardia lamblia | GTOR | 0.0039 | 0.0316 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.0316 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.01 ug ml-1 | Lowest concentration required to inhibit 90-100% in vitro growth of Candida neoformans | ChEMBL. | 11714609 |
MIC (functional) | = 0.01 ug ml-1 | Lowest concentration required to inhibit 90-100% in vitro growth of Candida neoformans | ChEMBL. | 11714609 |
MIC (functional) | = 2.5 ug ml-1 | Lowest concentration required to inhibit 90-100% in vitro growth of Candida albicans | ChEMBL. | 11714609 |
MIC (functional) | = 2.5 ug ml-1 | Lowest concentration required to inhibit 90-100% in vitro growth of Candida albicans | ChEMBL. | 11714609 |
MIC (functional) | = 20 ug ml-1 | Lowest concentration required to inhibit 90-100% in vitro growth of Aspergillus fumigatus | ChEMBL. | 11714609 |
Ratio (functional) | = 7.8 | Ratio of the drug concentration required to achieve 50% survival of fungal infection compared with untreated animals to that of ED50 of PSB | ChEMBL. | 11714609 |
Ratio (functional) | = 7.8 | Ratio of the drug concentration required to achieve 50% survival of fungal infection compared with untreated animals to that of ED50 of PSB | ChEMBL. | 11714609 |
Toxicity (functional) | Tail vein toxicity at 20 mg/kg dose was determined in mice. | ChEMBL. | 11714609 | |
Toxicity (functional) | 0 | Tail vein toxicity at 20 mg/kg dose was determined in mice. | ChEMBL. | 11714609 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.